When you walk into Juno Therapeutics‘ new headquarters in Seattle, your eyes are immediately drawn to the view. The office’s 12th-floor reception desk offers a stunning panorama of the Olympic mountains,… Read More
Omeros, one of Seattle’s biggest biotech companies, may have its hands on a lucrative new drug — but questions about the drug and how it has been studied, first raised… Read More
The idea is simple: when a patient has a bacterial infection, doctors should find out what kind of bacteria it is so they can give the most effective treatment. But… Read More
Despite a vibrant maker culture, and one of the top biotech industries in the nation, Seattle has never had a strong DIYbio community — a loose movement of amateur and professional scientists, working on creative… Read More
BGI, the Shenzhen, China,-based genomics giant, announced today that it has opened a Seattle office as part of a major expansion in North America. The company is one of the largest… Read More
Seattle-based Aptevo Therapeutics completed a spinoff from Emergent BioSolutions Monday, making a debut in the public markets as a standalone company. They are the second Seattle-area biotech company to go public… Read More